Cross-Ministerial Partnerships
Multi-Ministerial Funding Program (Since 2025)
Building a centralized supply system for clinical research materials and advancing full-stage immune cell gene therapy development through multi-ministerial collaboration.- Title of Program
- Development of CAR-X Platform Technologies for Solid Tumors
- Objective
- Developing platform technologies for CAR-X therapies that selectively target solid tumors.
Viral Vector & T Cell Manufacturing
Clinical Research Planning Support
Clinical Research Planning Support
MSIT(NRF)
- Basic & Platform
Technology
Development -
Next-generation CAR platform
technologies for solid tumors- Gene delivery and tumor microenvironment
- Switchable and controllable CAR technologies
MOHW(NCC)
- Early Clinical Development
-
Full-Stage Development of Immune Cell GeneTherapy
- Supporting advanced regenerative medicine clinical research
(CAR-T / TCR-T / TIL)
- Supporting advanced regenerative medicine clinical research
MFDS(KHIDI)
- Regulatory Alignment
- Evaluation technologies for the quality, safety, and efficacy of TCR-T and TIL therapies
Viral Vector & T Cell Manufacturing
Clinical Research Planning Support
Clinical Research Planning Support
MSIT(NRF)
MOHW(NCC)
MFDS(KHIDI)
MOHW(NCC)
Early Clinical Development
Full-Stage Development of Immune Cell GeneTherapy
- Supporting advanced regenerative medicine clinical research (CAR-T / TCR-T / TIL)
MSIT(NRF)
Basic & Platform Technology Development
Next-generation CAR platform technologies for solid tumor therapy
- Gene delivery and tumor microenvironment
- Switchable and controllable CAR technologies
MFDS(KHIDI)
RegulatoryAlignment
Evaluation technologies for the quality, safety, and efficacy of TCR-T and TIL therapies
Strategy
Manufacturing and Supply of Clinical Research Materials and Sharing of Research Outputs
- Viral Vector
and T Cell Manufacturing - CAR-T/TCR-T
Clinical Research - Neoantigen-Reactive
TIL Clinical Research
CAR-T/TCR-T Clinical Research
- NCC
-
Manufacture & Supply of Viral Vectors,
CAR-T/TCR-T Cells at GMP-grade
- Researchers
-
Conduct Advanced Regenerative
Medicine Clinical Research
- Shared CMC Knowledge Data
TIL Clinical Research
- NCC
-
Initial TIL Culture &
GMP Manufacturing
- NCC Researchers
-
Tumor Tissue Collection &
Basket Clinical Research
- Neoantigen-Specific TCR Patents
- TCR Database